CFN Acquires a Distributor in U.K. - Analyst Blog

Comment

Shutterstock photo

CareFusion ( CFN ) recently revealed the takeover of U.K. Medical Limited, a distributor of medical offerings to the private health sector in the U.K. as well as the National Health Service ("NHS") of that country. U.K. Medical, however, mainly catered to the NHS and distributed many one-time-use medical offerings used in surgery, biopsy, gynecology, obstetrics, drainage, cardiac and other functions. CareFusion did not provide information on the terms of the transaction.  

This takeover bolsters CareFusion's role in the U.K. where it has already created a leadership position for itself in infection prevention and infusion therapy. This acquisition is a natural outcome of the long-standing cooperation between CareFusion and U.K. Medical. With this takeover, CareFusion is in a stronger position to harness its clinical expertise in that country.

U.K. Medical is CareFusion's fifth takeover, integral to its strategy to grow in the global markets. The U.K.-based distributor enjoyed robust client relationships and clinical know-how on latest medical technologies, including offerings used in acute-care facilities.

U.K. Medical was the only distributor in the U.K. of CareFusion's Interventional Technologies set up. Furthermore, it has been a major contributor to growth in CareFusion's Interventional Technologies business.

For its part, U.K. Medical expressed the hope that, as part of CareFusion, it would continue to serve the medical industry of the U.K. with top class medical offerings.

CareFusion is a global company catering to the health care industry with offerings that enable hospitals enhance the safety and quality of care. Following the spin-off of CareFusion a few years ago, the new Cardinal Health ( CAH ) and CareFusion businesses began to trade in the bourses.


 
CARDINAL HEALTH (CAH): Free Stock Analysis Report
 
CAREFUSION CORP (CFN): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.



This article appears in: Investing , Business , Stocks
More Headlines for: CAH , CFN


More from Zacks.com

Subscribe






Zacks.com
Contributor:

Zacks.com

Equity Research
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com